Literature DB >> 25911531

Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder.

Yuri Sheikine1, Craig B Woda, Pui Y Lee, Talal A Chatila, Sevgi Keles, Louis-Marie Charbonnier, Birgitta Schmidt, Seymour Rosen, Nancy M Rodig.   

Abstract

BACKGROUND: Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder is an autoimmune disease caused by loss-of-function mutations in the gene encoding the forkhead box P3 (FOXP3) transcription factor. These mutations affect the normal function of circulating regulatory T cells. IPEX is characterized by profound immune dysregulation leading to dermatitis, enteropathy, multiple endocrinopathies and failure to thrive. Different forms of renal injury have also been noted in these patients but these have been described to a very limited extent. CASE-DIAGNOSIS: Three patients with IPEX with characteristic renal findings and mutations in FOXP3, including one novel mutation, are described. Case presentations are followed by a review of the renal manifestations noted in IPEX and the range of therapeutic options for this disorder.
CONCLUSIONS: We recommend that IPEX be considered in the differential diagnosis of young children who present with signs of immune dysregulation with a concomitant renal biopsy demonstrating immune complex deposition in a membranous-like pattern and/or interstitial nephritis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911531     DOI: 10.1007/s00467-015-3102-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy.

Authors:  Nicolette Moes; Frédéric Rieux-Laucat; Bernadette Begue; Julien Verdier; Bénédicte Neven; Natacha Patey; Troy T Torgerson; Capucine Picard; Marie-Claude Stolzenberg; Corinne Ruemmele; Edmond Hhm Rings; Jean-Laurent Casanova; Hugues Piloquet; Armand Biver; Anne Breton; Hans D Ochs; Olivier Hermine; Alain Fischer; Olivier Goulet; Nadine Cerf-Bensussan; Frank M Ruemmele
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

2.  Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Lauri M Burroughs; Troy R Torgerson; Rainer Storb; Paul A Carpenter; David J Rawlings; Jean Sanders; Andrew M Scharenberg; Suzanne Skoda-Smith; Janet Englund; Hans D Ochs; Ann E Woolfrey
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

3.  A potential screening tool for IPEX syndrome.

Authors:  Meredith Lee Heltzer; John K Choi; Hans D Ochs; Kathleen E Sullivan; Troy R Torgerson; Linda M Ernst
Journal:  Pediatr Dev Pathol       Date:  2007 Mar-Apr

4.  The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies.

Authors:  Masanobu Tsuda; Troy R Torgerson; Carlo Selmi; Eleonora Gambineri; Magda Carneiro-Sampaio; Sara Ciullini Mannurita; Patrick S C Leung; Gary L Norman; M Eric Gershwin
Journal:  J Autoimmun       Date:  2010-07-22       Impact factor: 7.094

5.  Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome).

Authors:  Lutz Bindl; Troy Torgerson; Lucia Perroni; Nelly Youssef; Hans D Ochs; Olivier Goulet; Frank M Ruemmele
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

Review 6.  Autoimmune polyglandular syndromes.

Authors:  Aaron W Michels; Peter A Gottlieb
Journal:  Nat Rev Endocrinol       Date:  2010-03-23       Impact factor: 43.330

7.  Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China.

Authors:  Y-F An; F Xu; M Wang; Z-Y Zhang; X-D Zhao
Journal:  Scand J Immunol       Date:  2011-09       Impact factor: 3.487

8.  Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX).

Authors:  I Kobayashi; R Shiari; M Yamada; N Kawamura; M Okano; A Yara; A Iguchi; N Ishikawa; T Ariga; Y Sakiyama; H D Ochs; K Kobayashi
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

Review 9.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

10.  Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: an unusual cause of proteinuria in infancy.

Authors:  Asha Moudgil; Paige Perriello; Brett Loechelt; Ronald Przygodzki; Wendy Fitzerald; Naynesh Kamani
Journal:  Pediatr Nephrol       Date:  2007-07-13       Impact factor: 3.714

View more
  12 in total

1.  PLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome.

Authors:  Teresa Chuva; Frederick Pfister; Ortraud Beringer; Kerstin Felgentreff; Maike Büttner-Herold; Kerstin Amann
Journal:  Pediatr Nephrol       Date:  2017-05-09       Impact factor: 3.714

Review 2.  Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.

Authors:  Laurie S Davis; Andreas M Reimold
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

3.  FOXP3+ T cells are present in kidney biopsy samples in children with tubulointerstitial nephritis and uveitis syndrome.

Authors:  Sari H Rytkönen; Petri Kulmala; Helena Autio-Harmainen; Pekka Arikoski; Kira Endén; Janne Kataja; Tuomo Karttunen; Matti Nuutinen; Timo Jahnukainen
Journal:  Pediatr Nephrol       Date:  2017-09-11       Impact factor: 3.714

4.  DOCK8 Deficiency Presenting as an IPEX-Like Disorder.

Authors:  Fayhan J Alroqi; Louis-Marie Charbonnier; Sevgi Keles; Fatima Ghandour; Pierre Mouawad; Rami Sabouneh; Reem Mohammed; Abduarahman Almutairi; Janet Chou; Michel J Massaad; Raif S Geha; Zeina Baz; Talal A Chatila
Journal:  J Clin Immunol       Date:  2017-10-23       Impact factor: 8.317

Review 5.  A novel FOXP3 mutation in a Chinese child with IPEX-associated membranous nephropathy.

Authors:  Liwen Tan; Yunfei An; Qin Yang; Haiping Yang; Gaofu Zhang; Qiu Li; Mo Wang
Journal:  Mol Genet Genomic Med       Date:  2022-04-18       Impact factor: 2.473

6.  Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome.

Authors:  Sanem Eren Akarcan; Neslihan Edeer Karaca; Guzide Aksu; Ayca Aykut; Deniz Yilmaz Karapinar; Funda Cetin; Yesim Aydinok; Elif Azarsiz; Eleonora Gambineri; Ozgur Cogulu; Ezgi Ulusoy Severcan; Hudaver Alper; Necil Kutukculer
Journal:  JMM Case Rep       Date:  2018-10-15

7.  Atypical late-onset severe gastritis in immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome: 2 case reports.

Authors:  Youhong Fang; Youyou Luo; Jingan Lou; Jie Chen
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

Review 8.  IL-2 Signaling Axis Defects: How Many Faces?

Authors:  Filippo Consonni; Claudio Favre; Eleonora Gambineri
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

9.  Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study.

Authors:  R Duclaux-Loras; F Charbit-Henrion; B Neven; J Nowak; S Collardeau-Frachon; C Malcus; P F Ray; D Moshous; J Beltrand; O Goulet; N Cerf-Bensussan; A Lachaux; F Rieux-Laucat; F M Ruemmele
Journal:  Clin Transl Gastroenterol       Date:  2018-11-02       Impact factor: 4.488

10.  Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

Authors:  Federica Barzaghi; Laura Cristina Amaya Hernandez; Benedicte Neven; Silvia Ricci; Zeynep Yesim Kucuk; Jack J Bleesing; Zohreh Nademi; Mary Anne Slatter; Erlinda Rose Ulloa; Anna Shcherbina; Anna Roppelt; Austen Worth; Juliana Silva; Alessandro Aiuti; Luis Murguia-Favela; Carsten Speckmann; Magda Carneiro-Sampaio; Juliana Folloni Fernandes; Safa Baris; Ahmet Ozen; Elif Karakoc-Aydiner; Ayca Kiykim; Ansgar Schulz; Sandra Steinmann; Lucia Dora Notarangelo; Eleonora Gambineri; Paolo Lionetti; William Thomas Shearer; Lisa R Forbes; Caridad Martinez; Despina Moshous; Stephane Blanche; Alain Fisher; Frank M Ruemmele; Come Tissandier; Marie Ouachee-Chardin; Frédéric Rieux-Laucat; Marina Cavazzana; Waseem Qasim; Barbarella Lucarelli; Michael H Albert; Ichiro Kobayashi; Laura Alonso; Cristina Diaz De Heredia; Hirokazu Kanegane; Anita Lawitschka; Jong Jin Seo; Marta Gonzalez-Vicent; Miguel Angel Diaz; Rakesh Kumar Goyal; Martin G Sauer; Akif Yesilipek; Minsoo Kim; Yesim Yilmaz-Demirdag; Monica Bhatia; Julie Khlevner; Erick J Richmond Padilla; Silvana Martino; Davide Montin; Olaf Neth; Agueda Molinos-Quintana; Justo Valverde-Fernandez; Arnon Broides; Vered Pinsk; Antje Ballauf; Filomeen Haerynck; Victoria Bordon; Catharina Dhooge; Maria Laura Garcia-Lloret; Robbert G Bredius; Krzysztof Kałwak; Elie Haddad; Markus Gerhard Seidel; Gregor Duckers; Sung-Yun Pai; Christopher C Dvorak; Stephan Ehl; Franco Locatelli; Frederick Goldman; Andrew Richard Gennery; Mort J Cowan; Maria-Grazia Roncarolo; Rosa Bacchetta
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.